Results 161 to 170 of about 63,660 (228)

ARPE-19-derived VEGF-containing exosomes promote neovascularization in HUVEC: the role of the melanocortin receptor 5. [PDF]

Cell Cycle, 2019
Maisto R, Oltra M, Vidal-Gil L, Martínez-Gil N, Sancho-Pellúz J, Filippo CD, Rossi S, D Amico M, Barcia JM, Romero FJ.   +9 more
europepmc   +1 more source

Melanocortin 4 Receptor Deficiency [PDF]

, 2020
openaire   +1 more source

Strategies to deliver peptide drugs to the brain [PDF]

, 2014
Lalatsa, Katerina, Schatzlein, Andreas G., Uchegbu, Ijeoma F.   +2 more
core   +1 more source

Melanocortin 4 receptor (MC4R) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Setmelanotide, a Novel, Selective Melanocortin Receptor-4 Agonist Exerts Anti-inflammatory Actions in Astrocytes and Promotes an Anti-inflammatory Macrophage Phenotype. [PDF]

Front Immunol, 2019
Kamermans A, Verhoeven T, van Het Hof B, Koning JJ, Borghuis L, Witte M, van Horssen J, de Vries HE, Rijnsburger M.   +8 more
europepmc   +1 more source

The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases. [PDF]

Curr Protein Pept Sci, 2016
Cai M, Hruby VJ.
europepmc   +1 more source

Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide. [PDF]

J Hypertens, 2017
White WB, Myers MG, Jordan R, Lucas J.
europepmc   +1 more source

MC-5 Melanocortin Receptor

, 2007
S.J. Enna, David B. Bylund
openaire   +1 more source

Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1. [PDF]

J Med Chem, 2018
Durek T, Cromm PM, White AM, Schroeder CI, Kaas Q, Weidmann J, Ahmad Fuaad A, Cheneval O, Harvey PJ, Daly NL, Zhou Y, Dellsén A, Österlund T, Larsson N, Knerr L, Bauer U, Kessler H, Cai M, Hruby VJ, Plowright AT, Craik DJ.   +20 more
europepmc   +1 more source